Long-term Efficacy of Erenumab in Patients with Chronic Migraine Who Failed Prior Prophylactic Treatment

被引：0
|
作者：
Ashina, M. [1 ]
Tepper, S. J. [2 ]
Brandes, J. [3 ]
Boudreau, G. [4 ]
Dolezil, D. [5 ]
Klatt, J. [6 ]
Zhang, F. [7 ]
Cheng, S. [7 ]
Mikol, D. D. [7 ]
机构：
[1] Rigshosp Glostrup, Glostrup, Hovedstaden, Denmark
[2] Dartmouth Hitchcock Med Ctr, Dept Neurol, Lebanon, NH 03766 USA
[3] Nashville Neurosci Grp, Nashville, TN USA
[4] Ctr Traitement Neurol, Montreal, PQ, Canada
[5] Prague Headache Ctr, Prague, Jihocesky Kraj, Czech Republic
[6] Novartis Pharma AG, Basel, Basel Stadt, Switzerland
[7] Amgen Inc, Thousand Oaks, CA USA
来源：
HEADACHE | 2018年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PF106LB
引用
收藏
页码：1296 / 1297
页数：2
相关论文
共 50 条
  • [31] Long-Term Efficacy of Fremanezumab in Patients Who Reverted from a Chronic to an Episodic Migraine Classification
    Lipton, R. B.
    Cohen, J. M.
    Yang, R.
    Seminerio, M. J.
    Campos, V. Ramirez
    Singh, R. B. Walker
    Ailani, J.
    HEADACHE, 2019, 59 : 101 - 102
  • [32] Long-Term Efficacy of Fremanezumab in Patients Who Reverted From a Chronic to an Episodic Migraine Classification
    Lipton, Richard
    Cohen, Joshua
    Yeung, Paul P.
    Yang, Ronghua
    Seminerio, Michael
    Campos, Verena Ramirez
    Singh, Rashmi Halker
    Ailani, Jessica
    NEUROLOGY, 2019, 92 (15)
  • [33] Long-term Efficacy of Fremanezumab in Patients With Chronic or Episodic Migraine Who Were Inadequate Responders to Initial Fremanezumab Treatment
    Silberstein, Stephen D.
    Ortega, Mario
    Elms, Shawn
    Davis, Matthew
    Cohen, Joshua M.
    Seminerio, Michael
    Gross, Nick
    Blumenfeld, Andrew
    NEUROLOGY, 2021, 96 (15)
  • [34] Efficacy of erenumab for the treatment of patients with chronic migraine in presence of medication overuse
    Diener, H. -C.
    Ashina, M.
    Brandes, J.
    Friedman, D.
    Reuter, U.
    Tepper, S.
    Cheng, S.
    Leonardi, D.
    Lenz, R.
    Mikol, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 472 - 472
  • [35] Efficacy of erenumab for the treatment of patients with chronic migraine in presence of medication overuse
    Tepper, Stewart J.
    Diener, Hans-Christoph
    Ashina, Messoud
    Brandes, Jan L.
    Friedman, Deborah T.
    Reuter, Uwe
    Cheng, Sunfa
    Leonardi, Dean
    Lenz, Robert A.
    Mikol, Daniel D.
    CEPHALALGIA, 2017, 37 : 33 - 34
  • [36] Efficacy of Erenumab for the Treatment of Patients with Chronic Migraine in Presence of Medication Overuse
    Tepper, S. J.
    Diener, H.
    Ashina, M.
    Brandes, J. L.
    Friedman, D., I
    Reuter, U.
    Cheng, S.
    Leonardi, D. K.
    Lenz, R. A.
    Mikol, D. D.
    HEADACHE, 2017, 57 : 197 - 197
  • [37] Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab
    Bolchini, Marco
    Schiano di Cola, Francesca
    Ceccardi, Giulia
    Caratozzolo, Salvatore
    Liberini, Paolo
    Rao, Renata
    Padovani, Alessandro
    EUROPEAN NEUROLOGY, 2023, 86 (02) : 135 - 139
  • [38] Prophylactic treatment of migraine with topamax: Long-term results
    Azimova Yu.É.
    Tabeeva G.R.
    Neuroscience and Behavioral Physiology, 2007, 37 (2) : 125 - 127
  • [39] Efficacy of Erenumab in chronic migraine patients with and without allodynia
    Lipton, R.
    Buse, D.
    Dodick, D.
    Richards, S.
    Klatt, J.
    Mikol, D. D.
    Cheng, S.
    Chou, D.
    Snellman, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 219 - 219
  • [40] Efficacy of Erenumab in Chronic Migraine Patients With and Without Allodynia
    Chou, Denise
    Buse, Dawn
    Dodick, David
    Richards, Sharon
    Klatt, Jan
    Mikol, Daniel
    Cheng, Sunfa
    Lipton, Richard
    NEUROLOGY, 2019, 92 (15)
12345